Ann: Cirralto to Present at NWR Virtual Investor Conference, page-53

the Prospa guy is no longer with Invigo - left when CRO purchased them. Completely different company to Invigo as well and chases the small end business loans that banks won’t do - higher risk but hasnt affected their valuation. There are many very prosperous invoice finance companies - Scotpac,CML etc - NAB do it well, combank getting back into it - there’s big money to be made. However it’s just not invoice finance they will be offering - it’s also trade finance where you have security over stock as well. E.g lien over the cattle. Furthermore CRO is not funding into the high risk sectors such as construction and if they were, they would have an insurance policy to offset this, as most invoice finance companies do - no insurance, no funding. Try and downramp as much as you want but this funding is a huge winner and will deliver tremendous results - afterpay was suffering like 20% of bad debts and just sold for $39B